2002
Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
Ickovics J, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR, Acosta E, Barnett R, Bell D, Cannmann S, Eron J, Fischl M, Marschner I, Martinez A, Morse G, Pettinelli C, Sommadossi J, Wood K, Murphy R, Priller N, Sha B, French N, van der Horst C, Marcus C, Lane T, Horton J, Schooley R, Putnam B, Shugarts D, Johnson S, Fife K, Black J, Heise D, Todd K, Bagur J, Vazquez G, Lopez I, Ramirez V, Hill R, Wright S, McCulloch B, Saag M, Slamowitz D, Cain P, Merigan T, Tallman V, Greisberger C, Shoemaker M, Lewis M, Hewitt R, Havlir D, Nuffer K, Wininger D, Watson S, Clark J, Jackson C, Rodriguez A, Scerpella E, Tebas P, Stiffler T, Royal M, Powderly W, Collier A, Storey S, Houseworth L, Conley N, Lederman M, Kalayjian B, Ingersol K, McVey R, Gluckman S, Helker C, Kappes R, Kim D, Albrecht M, Koziol C, Govan; T, Miles S, Chafey S, Mitsuyasu R, Sacks H, Mildvan D, Shikuma C, Millard M, Souza S. Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370. Antiviral Therapy 2002, 7: 185-193. PMID: 12487386, DOI: 10.1177/135965350200700308.Peer-Reviewed Original ResearchConceptsPlasma HIV-1 RNA levelsHIV-1 RNA levelsCD4 cell countWeek 24Adherence ratesClinical trialsBaseline plasma HIV-1 RNA levelsAdult AIDS Clinical Trials GroupCell countAIDS Clinical Trials GroupRNA levelsAIDS clinical trialsAdverse clinical eventsAssociation of adherenceOverall adherence rateDeterminants of adherenceClinical Trials GroupSelf-reported adherencePredictors of adherencePatterns of adherenceNon-nucleoside reversePotential confounding variablesVirological outcomesAntiretroviral therapyAdverse events
1997
Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection
Ickovics J, Chesney M. Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection. JAMA 1997, 278: 1233-1234. PMID: 9333258, DOI: 10.1001/jama.1997.03550150037025.Peer-Reviewed Original ResearchConceptsAdherence behaviorPlasma human immunodeficiency virus (HIV) RNA levelsHuman immunodeficiency virus (HIV) RNA levelsDrug resistanceVirus RNA levelsHIV-1 infectionDrug regimenHIV diseaseAntiretroviral treatmentViral loadTreatment regimensCombination therapyPatients' willingnessDisease progressionCostly regimensConsensus statementMore pillsPatient healthRegimensRNA levelsAdherenceDearth of informationTherapyBrief periodNonadherence